The estimated Net Worth of Todd Foley is at least $184 Million dollars as of 9 July 2021. Mr. Foley owns over 27,351 units of Rhythm Pharmaceuticals stock worth over $110,584,381 and over the last 11 years he sold RYTM stock worth over $72,931,898. In addition, he makes $247,843 as Independent Director at Rhythm Pharmaceuticals.
Sign up
Mr. Foley RYTM stock SEC Form 4 insiders trading
Todd has made over 38 trades of the Rhythm Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 27,351 units of RYTM stock worth $917,626 on 9 July 2021.
The largest trade he's ever made was selling 1,000,000 units of Rhythm Pharmaceuticals stock on 15 March 2021 worth over $25,100,000. On average, Todd trades about 63,592 units every 53 days since 2014. As of 9 July 2021 he still owns at least 2,242,636 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Mr. Foley stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Todd Foley biography
Todd Foley serves as Independent Director of the Company. Mr. Foley has served as a member of our Board since 2014. Mr. Foley is a managing director with MPM Capital, a venture capital firm. Mr. Foley joined MPM Capital in 1999. Prior to joining MPM Capital, Mr. Foley worked in business development at Genentech, Inc. and in management consulting with Arthur D. Little, Inc. Mr. Foley currently serves as a member of the board of directors of Chiasma, Inc. Mr. Foley also serves on the boards of directors of numerous private companies, including Coda Biotherapeutics, Inc., Iconic Therapeutics, Inc., Repare Therapeutics Inc., Entrada Therapeutics, Inc. and Tetherex Pharmaceuticals, Inc. Mr. Foley received a B.S. in chemistry from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.
What is the salary of Todd Foley?
As the Independent Director of Rhythm Pharmaceuticals, the total compensation of Todd Foley at Rhythm Pharmaceuticals is $247,843. There are 12 executives at Rhythm Pharmaceuticals getting paid more, with Hunter Smith having the highest compensation of $1,922,850.
How old is Todd Foley?
Todd Foley is 48, he's been the Independent Director of Rhythm Pharmaceuticals since 2014. There are 12 older and 5 younger executives at Rhythm Pharmaceuticals. The oldest executive at Rhythm Pharmaceuticals Inc. is Dr. David P. Meeker M.D., 67, who is the Chairman, Pres & CEO.
What's Todd Foley's mailing address?
Todd's mailing address filed with the SEC is C/O MPM CAPITAL, 450 KENDALL STREET, CAMBRIDGE, MA, 02142.
Insiders trading at Rhythm Pharmaceuticals
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over $83,445,563 worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth $106,961,700 . The most active insiders traders include Forest Baskett, Scott D Sandell und Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of $3,358,405. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth $77,963.
What does Rhythm Pharmaceuticals do?
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
What does Rhythm Pharmaceuticals's logo look like?
Complete history of Mr. Foley stock trades at Chiasma Inc, Rhythm Pharmaceuticals und Repare Therapeutics
Rhythm Pharmaceuticals executives and stock owners
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include:
-
Hunter Smith,
Chief Financial Officer -
Dr. David P. Meeker M.D.,
Chairman, Pres & CEO -
Yann Mazabraud,
Exec. VP & Head of International -
Hunter C. Smith M.B.A.,
CFO & Treasurer -
Hunter C. Smith,
CFO, Treasurer & Sec. -
Jennifer L. Chien,
Exec. VP & Head of North America -
Joseph Shulman,
Chief Technical Officer -
Jennifer Good,
Independent Director -
Stuart Arbuckle,
Independent Director -
David Meeker,
Chairman of the Board, President, Chief Executive Officer -
David McGirr,
Independent Director -
Christophe Jean,
Independent Director -
Todd Foley,
Independent Director -
Edward Mathers,
Independent Director -
Dr. David P. Meeker,
Chairman, Pres & CEO -
Yann Mazabraud,
Executive Vice President, Head of International -
Hannah Deresiewicz,
IR Contact Officer -
Pamela Cramer,
Chief HR Officer -
Sarah Ryan,
VP of Sales & Marketing -
William T. Roberts,
Chief Accounting Officer -
Dr. Alastair Garfield Ph.D.,
VP & Head of Research -
Dr. Murray W. Stewart M.D.,
Chief Medical Officer -
Simon D. Kelner,
Chief HR Officer -
Satej Bhandarkar,
Sr. VP of Program Management, Strategy & Corp. Devel. -
Jim Flaherty,
Sr. VP & Gen. Counsel -
David Connolly,
Head of Investor Relations & Corp. Communications -
Rock Ventures Lp Third Rock...,
-
Fred T. Fiedorek,
Chief Medical Officer -
Nithya Desikan,
Chief Commercial Officer -
Der Ploeg Leonardus H.T. Van,
Chief Scientific Officer -
Neil Exter,
Director -
Rock Ventures Lp Third Rock...,
-
Bioventures V, L.P.Evnin Lu...,
-
Ravi Viswanathan,
10% owner -
Scott D Sandell,
10% owner -
David M Mott,
10% owner -
Patrick J Kerins,
10% owner -
Forest Baskett,
10% owner -
Peter J Barris,
10% owner -
M James Barrett,
10% owner -
Enterprise Associates 13 Lp...,
-
Inc Pfizer,
10% owner -
S.A. Ipsen,,
10% owner -
Advisors Llc Orbi Med Capit...,
-
Jonathan Silverstein,
Director -
Harbor Master Investors (Ca...,
10% owner -
James E Deerfield Mgmt L.P....,
-
Bros. Advisors Lp Baker Bro...,
-
Simon Kelner,
Chief Human Resources Officer -
Murray Stewart,
Chief Medical Officer -
Advisors Llc Orbi Med Capit...,
-
William T. Roberts,
Chief Accounting Officer -
Keith Michael Gottesdiener,
CEO & President -
Capital Management, L.P.Ra ...,
-
Jennifer Kayden Lee,
EVP, Head of North America -
Joseph Shulman,
Chief Technical Officer -
Lynn A. Tetrault,
Director -
Pamela J. Cramer,
Chief Human Resources Officer -
Linda Shapiro Manning,
Chief Medical Officer -
Christopher Paul German,
Corporate Controller & CAO -
Alastair Garfield,
Chief Scientific Officer